Atlas Venture Opportunity Fund I, L.P.
Insider CIK 1759241 · GBIO 10% owner · AKRO 10% owner · KYMR 10% owner · IRON 10% owner · DYN 10% owner · VIGL 10% owner · IKNA 10% owner · XLO 10% owner · DAWN 10% owner · THRD 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 116,693 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 60 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 711,193 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-07 | 4,808,896 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-07 | 1,027,978 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-13 | 1,386 | $42.84 | $59.4K | 828,830 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-13 | 22,779 | $42.19 | $961.0K | 830,216 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-13 | 6,686 | $42.84 | $286.4K | 4,676,075 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-13 | 108,404 | $42.19 | $4.57M | 4,682,761 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-13 | 126,066 | $41.94 | $5.29M | 4,799,746 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-13 | 8,581 | $42.52 | $364.9K | 4,791,165 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-13 | 26,452 | $41.94 | $1.11M | 854,814 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-13 | 1,819 | $42.52 | $77.3K | 852,995 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-13 | 5,122 | $43.42 | $222.4K | 4,925,812 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-13 | 37,180 | $42.77 | $1.59M | 4,930,934 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-13 | 7,837 | $42.77 | $335.2K | 882,311 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-13 | 1,045 | $43.42 | $45.4K | 881,266 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-01 | 2024-03-05 | 29,435 | $30.05 | $884.5K | 1,458,691 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-01 | 2024-03-05 | 17,099 | $30.05 | $513.8K | 847,388 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 210 | $25.25 | $5.3K | 864,487 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 13,109 | $24.83 | $325.5K | 864,697 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 360 | $25.25 | $9.1K | 1,488,126 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 22,567 | $24.83 | $560.3K | 1,488,486 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 2,430 | $25.25 | $61.4K | 5,698,091 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 152,244 | $24.83 | $3.78M | 5,700,521 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 40,455 | $24.38 | $986.3K | 1,514,874 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 2,216 | $24.68 | $54.7K | 877,806 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 23,505 | $24.38 | $573.1K | 880,022 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 3,821 | $24.68 | $94.3K | 1,511,053 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 25,779 | $24.68 | $636.2K | 5,852,765 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 272,923 | $24.38 | $6.65M | 5,878,544 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 136,312 | $23.59 | $3.22M | 6,216,250 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 64,783 | $23.98 | $1.55M | 6,151,467 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 20,205 | $23.59 | $476.6K | 1,564,932 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 5,580 | $23.98 | $133.8K | 903,527 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 11,736 | $23.59 | $276.9K | 909,107 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 9,603 | $23.98 | $230.3K | 1,555,329 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-23 | 2024-02-23 | 23,648 | $22.70 | $536.8K | 1,585,137 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-23 | 2024-02-23 | 159,542 | $22.70 | $3.62M | 6,352,562 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-23 | 2024-02-23 | 13,738 | $22.70 | $311.9K | 920,843 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-22 | 2024-02-23 | 119,360 | $22.66 | $2.70M | 6,512,104 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-21 | 2024-02-23 | 35,164 | $23.14 | $813.7K | 6,631,464 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-21 | 2024-02-23 | 149,337 | $22.44 | $3.35M | 6,666,628 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-09 | 733 | $0.64 | $469 | 2,019,563 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-09 | 267 | $0.64 | $171 | 734,546 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 20,000 | $67.65 | $1.35M | 198,326 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 47,500 | $67.65 | $3.21M | 1,402,186 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 82,500 | $67.65 | $5.58M | 703,660 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-01-12 | 2024-01-16 | 1,540 | $0.83 | $1.3K | 2,020,296 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-01-12 | 2024-01-16 | 560 | $0.83 | $465 | 734,813 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-01-11 | 2024-01-16 | 569 | $0.87 | $495 | 735,373 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-01-11 | 2024-01-16 | 1,566 | $0.87 | $1.4K | 2,021,836 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-01-10 | 2024-01-12 | 20,000 | $64.00 | $1.28M | 786,160 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-01-10 | 2024-01-12 | 30,000 | $64.00 | $1.92M | 1,449,686 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 120 | $59.74 | $7.2K | 806,160 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 180 | $59.74 | $10.8K | 1,479,686 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 20,429 | $58.27 | $1.19M | 806,280 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 30,645 | $58.27 | $1.79M | 1,479,866 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 3,508 | $59.99 | $210.4K | 826,749 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 40 | $60.50 | $2.4K | 826,709 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 60 | $60.50 | $3.6K | 1,510,511 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 5,263 | $59.99 | $315.7K | 1,510,571 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 9,901 | $65.77 | $651.2K | 1,515,834 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 18,615 | $65.10 | $1.21M | 836,856 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 27,924 | $65.10 | $1.82M | 1,525,735 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 688 | $63.78 | $43.9K | 855,471 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 1,031 | $63.78 | $65.8K | 1,553,659 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 665 | $62.90 | $41.8K | 856,159 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 994 | $62.90 | $62.5K | 1,554,690 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 4,155 | $62.42 | $259.4K | 856,824 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 6,234 | $62.42 | $389.1K | 1,555,684 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 422 | $60.99 | $25.7K | 860,979 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 632 | $60.99 | $38.5K | 1,561,918 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 20,823 | $59.87 | $1.25M | 861,401 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 31,235 | $59.87 | $1.87M | 1,562,550 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 6,599 | $65.77 | $434.0K | 830,257 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-08-15 | 2023-08-16 | 111,069 | $52.40 | $5.82M | 1,951,234 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-08-15 | 2023-08-16 | 72,931 | $52.40 | $3.82M | 882,224 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-08-14 | 2023-08-16 | 2,000 | $54.80 | $109.6K | 2,062,303 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-08-14 | 2023-08-16 | 98,000 | $53.00 | $5.19M | 2,064,303 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-08-14 | 2023-08-16 | 75,000 | $52.00 | $3.90M | 2,162,303 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-01-12 | 2023-01-13 | 21,592 | $30.29 | $654.0K | 890,148 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-01-12 | 2023-01-13 | 77,128 | $30.29 | $2.34M | 4,968,114 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-01-11 | 2023-01-13 | 21,683 | $29.96 | $649.6K | 5,045,242 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-01-11 | 2023-01-13 | 6,071 | $29.96 | $181.9K | 911,740 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 1,835,799 | — | $0 | 2,237,303 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 882,224 | — | $0 | 955,156 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-15 | 2022-12-16 | 717 | $30.00 | $21.5K | 917,811 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-15 | 2022-12-16 | 2,561 | $30.00 | $76.8K | 5,066,925 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 112,819 | $30.28 | $3.42M | 5,252,744 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 101,189 | $31.44 | $3.18M | 5,151,555 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 54,737 | $32.33 | $1.77M | 5,096,818 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 13,997 | $33.34 | $466.7K | 5,082,821 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 3,733 | $34.02 | $127.0K | 918,528 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 3,919 | $33.34 | $130.7K | 922,261 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 15,324 | $32.33 | $495.4K | 926,180 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 28,329 | $31.44 | $890.7K | 941,504 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 31,584 | $30.28 | $956.4K | 969,833 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-12-14 | 2022-12-16 | 13,335 | $34.02 | $453.7K | 5,069,486 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2022-12-12 | 2022-12-14 | 934,581 | $10.70 | $10.00M | 934,581 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 21,085 | $30.00 | $632.5K | 1,001,417 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 75,312 | $30.00 | $2.26M | 5,365,563 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 96,581 | $30.02 | $2.90M | 5,440,875 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 27,038 | $30.02 | $811.7K | 1,022,502 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-01 | 3,727 | $31.08 | $115.8K | 5,537,456 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-01 | 1,044 | $31.08 | $32.4K | 1,049,540 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-01 | 56,455 | $30.57 | $1.73M | 5,541,183 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-01 | 15,804 | $30.57 | $483.1K | 1,050,584 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-01 | 94,239 | $30.23 | $2.85M | 5,597,638 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-01 | 26,383 | $30.23 | $797.6K | 1,066,388 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-10-28 | 2022-11-01 | 71,135 | $30.00 | $2.13M | 5,691,877 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-10-28 | 2022-11-01 | 19,915 | $30.00 | $597.5K | 1,092,771 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-19 | 2,282,537 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-19 | 648,447 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-19 | 594,096 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-19 | 3,541,390 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | P Buy | 2022-09-19 | 2022-09-19 | 300,000 | $17.00 | $5.10M | 10,313,763 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion | 2022-09-19 | 2022-09-19 | 6,472,374 | — | $0 | 10,013,763 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion | 2022-09-19 | 2022-09-19 | 594,096 | — | $0 | 594,096 | SEC↗ |
| DAWN Day One Biopharmaceuticals | J Other | 2022-07-01 | 2022-07-06 | 198,280 | — | $0 | 793,116 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy | 2022-06-17 | 2022-06-22 | 766,667 | $15.00 | $11.50M | 766,667 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 2,850,789 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 7,852,374 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion | 2022-01-11 | 2022-01-11 | 1,027,978 | — | $0 | 1,027,978 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | P Buy | 2022-01-11 | 2022-01-11 | 535,000 | $14.00 | $7.49M | 4,808,896 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion | 2022-01-11 | 2022-01-11 | 2,831,520 | — | $0 | 4,273,896 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-14 | 2021-12-14 | 5,959 | $14.00 | $83.4K | 1,241,935 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-13 | 2021-12-14 | 8,330 | $14.64 | $122.0K | 1,247,894 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-10 | 2021-12-14 | 11,989 | $15.03 | $180.2K | 1,256,224 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 13,043,477 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 5,210,204 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 5,928,852 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy | 2021-10-26 | 2021-10-26 | 187,500 | $16.00 | $3.00M | 735,942 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 1,372,998 | — | $0 | 1,399,313 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 624,089 | — | $0 | 2,023,402 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 548,442 | — | $0 | 548,442 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-29 | 2021-09-29 | 30 | $24.59 | $738 | 608 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-29 | 2021-09-29 | 16,556 | $24.59 | $407.1K | 0 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-28 | 2021-09-29 | 24 | $25.24 | $606 | 638 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-28 | 2021-09-29 | 13,089 | $25.24 | $330.4K | 16,556 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-27 | 2021-09-29 | 95 | $25.70 | $2.4K | 662 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-27 | 2021-09-29 | 51,294 | $25.70 | $1.32M | 29,645 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-24 | 2021-09-24 | 28,862 | $25.84 | $745.8K | 80,939 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-24 | 2021-09-24 | 54 | $25.84 | $1.4K | 757 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-23 | 2021-09-24 | 1 | $26.55 | $27 | 109,801 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-23 | 2021-09-24 | 75,324 | $26.13 | $1.97M | 109,802 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-23 | 2021-09-24 | 140 | $26.13 | $3.7K | 811 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-22 | 2021-09-24 | 30,560 | $25.89 | $791.2K | 185,126 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-09-22 | 2021-09-24 | 57 | $25.89 | $1.5K | 951 | SEC↗ |
| GBIO Generation Bio Co. | J Other | 2021-09-17 | 2021-09-21 | 100,000 | — | $0 | 1,166,937 | SEC↗ |
| GBIO Generation Bio Co. | J Other | 2021-09-17 | 2021-09-21 | 1,000,000 | — | $0 | 7,111,939 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-06-24 | 2021-06-28 | 8 | $26.39 | $211 | 608 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-06-24 | 2021-06-28 | 26,858 | $25.77 | $692.1K | 4,092 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-06-24 | 2021-06-28 | 50 | $25.77 | $1.3K | 616 | SEC↗ |
| GBIO Generation Bio Co. | S Sale | 2021-06-24 | 2021-06-28 | 4,092 | $26.39 | $108.0K | 0 | SEC↗ |
| GBIO Generation Bio Co. | J Other | 2021-06-16 | 2021-06-21 | 1,000,000 | — | $0 | 8,111,939 | SEC↗ |
| GBIO Generation Bio Co. | J Other | 2021-06-16 | 2021-06-21 | 100,000 | — | $0 | 1,266,937 | SEC↗ |
| DAWN Day One Biopharmaceuticals | C Conversion deriv | 2021-06-01 | 2021-06-02 | 7,761,380 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | C Conversion deriv | 2021-06-01 | 2021-06-02 | 741,396 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy | 2021-06-01 | 2021-06-02 | 250,000 | $16.00 | $4.00M | 250,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | C Conversion | 2021-06-01 | 2021-06-02 | 741,396 | — | $0 | 741,396 | SEC↗ |
| DAWN Day One Biopharmaceuticals | C Conversion | 2021-06-01 | 2021-06-02 | 7,761,380 | — | $0 | 7,761,380 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy | 2021-06-01 | 2021-06-02 | 250,000 | $16.00 | $4.00M | 250,000 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-12-14 | 125,000 | $16.00 | $2.00M | 874,634 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 5,362,888 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 9,499,999 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 11,258,117 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 7,863,094 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 2,901,609 | — | $0 | 2,901,609 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 749,634 | — | $0 | 749,634 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 1,099,118 | — | $0 | 1,268,213 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy deriv | 2021-02-01 | 2021-06-02 | 741,396 | — | $0 | 741,396 | SEC↗ |
| GBIO Generation Bio Co. | J Other | 2020-12-15 | 2020-12-17 | 1,151,882 | — | $0 | 11,478,876 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 20,000,000 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 5,336,179 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 1,608,785 | — | $0 | 1,608,785 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 6,029,726 | — | $0 | 8,140,130 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 1,774,624 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 3,000,000 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 7,000,000 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 1,477,832 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion | 2020-08-25 | 2020-08-25 | 1,112,686 | — | $0 | 1,112,686 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion | 2020-08-25 | 2020-08-25 | 7,196,584 | — | $0 | 7,948,982 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 15,051,020 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 268,269 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion | 2020-06-16 | 2020-06-18 | 10,040,032 | — | $0 | 12,630,758 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2020-02-07 | 2020-02-10 | 50,510 | — | $0 | 404,079 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2019-12-17 | 2019-12-19 | 50,510 | — | $0 | 454,589 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | J Other | 2019-12-17 | 2019-12-19 | 520,464 | — | $0 | 2,949,295 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 10,666,667 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 722,737 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2019-06-24 | 2019-06-25 | 270,000 | $16.00 | $4.32M | 505,099 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 235,099 | — | $0 | 235,099 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 3,469,759 | — | $0 | 3,469,759 | SEC↗ |